Lot-to-lot variability in cytokines and growth factors is a persistent cost and scale-up challenge in cell and gene therapy manufacturing — inconsistent raw materials can undermine process reproducibility long before a product reaches the clinic. Join this webinar for a look at how animal origin-free (AOF) recombinant cytokines and growth factors are being formulated to address these variability and documentation gaps.The session will cover lot-to-lot reproducibility data, bioactivity and protein recovery testing, and the regulatory documentation needed to support both research and GMP-compliant workflows. We'll also discuss how closed-system compatible formats factor into process development and scale-up planning for clinical and commercial manufacturing.
Key Takeaways:
Who should attend:
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the e-mail address you would like to be contacted at.